New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry
pharmaphorum
OCTOBER 27, 2022
The Guidance applies to all member companies of EFPIA and IFPMA, but also acts as useful guidance for all pharmaceutical companies as to how the authorities will interpret the legislative provisions to social media channels. The Guidance applies to both product-related and therapeutic-area-related activities.
Let's personalize your content